Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enfusion Inc Cl A (NY: ENFN )

9.050 +0.140 (+1.57%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

2012 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 13, 2012
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 14, 2012
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 15, 2012

2011 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 13, 2011
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 11, 2011
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 12, 2011
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 14, 2011

2010 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 14, 2010
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 11, 2010
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 12, 2010
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 15, 2010

2009 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 02, 2009
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 11, 2009
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 13, 2009
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 11, 2009

2008 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 12, 2008
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
August 11, 2008
Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
May 13, 2008
Form 10-K: Annual Corporate Report
Source: SEC/Edgar
March 13, 2008

2007 Reports

Form 10-Q: Quarterly Corporate Report
Source: SEC/Edgar
November 12, 2007
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.